Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy

The NAD(P)H quinone oxidoreductase (NQO1:EC 1.6.99.2) is an important biotransformation enzyme system that is also known to metabolize important novel chemotherapeutic compounds. The gene that codes for this enzyme has recently been found to be polymorphic in humans. Here, we describe the ethnic distribution of the polymorphism and note that this may have implications for anti-tumour drug development and use.

Abstract licence: CC BY

1. 1.

   Berenberg J. L. Response to treatment of breast cancer. Breast Cancer Res Treat. 1991;18(Suppl 1):S147-S155.

   Not in our library10.1007/bf02633548 (opens in a new tab)

2. 2.

   Elledge R. M., Clark G. M., Chamness G. C., Osborne C. K. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86(9):705-712.

   Not in our library10.1093/jnci/86.9.705 (opens in a new tab)

3. 3.

   Fitzsimmons S. A., Workman P., Grever M., Paull K., Camalier R., Lewis A. D. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst. 1996;88(5):259-269.

   Not in our library10.1093/jnci/88.5.259 (opens in a new tab)

4. 4.

   Modiano M. R., Villar-Werstler P., Meister J., Figueroa-Vallés N. Cancer in Hispanics: issues of concern. J Natl Cancer Inst Monogr. 1995;(18):35-39.

   Not in our library

5. 5.

   Philpott N. J., Bevan D. H., Gordon-Smith E. C. Secondary leukaemia after MMM combined modality therapy for breast carcinoma. Lancet. 1993;341(8855):1289-1289.

   Not in our library10.1016/0140-6736(93)91199-v (opens in a new tab)

6. 6.

   Riley R. J., Workman P. DT-diaphorase and cancer chemotherapy. Biochem Pharmacol. 1992;43(8):1657-1669.

   Not in our library10.1016/0006-2952(92)90694-e (opens in a new tab)

7. 7.

   Ross D., Beall H., Traver R. D., Siegel D., Phillips R. M., Gibson N. W. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. Oncol Res. 1994;6(10-11):493-500.

   Not in our library

8. 8.

   Ross D., Siegel D., Beall H., Prakash A. S., Mulcahy R. T., Gibson N. W. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev. 1993;12(2):83-101.

   Not in our library10.1007/bf00689803 (opens in a new tab)

9. 9.

   Ross D., Traver R. D., Siegel D., Kuehl B. L., Misra V., Rauth A. M. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer. 1996;74(6):995-996.

   Not in our library10.1038/bjc.1996.477 (opens in a new tab)

10. 10.

    Rosvold E. A., McGlynn K. A., Lustbader E. D., Buetow K. H. Re: Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst. 1995;87(23):1802-1803.

    Not in our library10.1093/jnci/87.23.1802 (opens in a new tab)

11. 11.

    Siegel D., Gibson N. W., Preusch P. C., Ross D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res. 1990;50(23):7483-7489.

    Not in our library

12. 12.

    Traver R. D., Horikoshi T., Danenberg K. D., Stadlbauer T. H., Danenberg P. V., Ross D., Gibson N. W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 1992;52(4):797-802.

    Not in our library

13. 13.

    Walton M. I., Smith P. J., Workman P. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun. 1991;3(7):199-206.

    Not in our library10.3727/095535491820873164 (opens in a new tab)

14. 14.

    Workman P. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol Res. 1994;6(10-11):461-475.

    Not in our library

• C609T polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin · 2013

  Not checked

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.